Dr. Aurora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-498-5840
Summary
- Dr. Sheena Aurora is a neurologist in Palo Alto, CA and is affiliated with Stanford Health Care. She received her medical degree from Christian Medical College Ludhiana and has been in practice 28 years. She specializes in headache and pain medicine and is experienced in headache medicine, migraine disorders, pain management, headache disorders, and botulinum toxin injections for headache. She has more than 100 publications and over 500 citings.
Education & Training
Christian Medical College LudhianaClass of 1989
Certifications & Licensure
CA State Medical License 2012 - 2025
WA State Medical License 2000 - 2025
IN State Medical License 2017 - 2021
MI State Medical License 1995 - 2002- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors Castle Connolly, 2009-2012
- Women's Health Castle Connolly, 2008
- Join now to see all
Clinical Trials
- Does Topiramate Adjust the Excitability of the Brain in Migraine Sufferers? Start of enrollment: 2006 Feb 01
- Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine. Start of enrollment: 2005 Dec 01
- A Study of a Melatonin Receptor Agonist to Prevent Migraine Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsEfficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trialsDustin D. Ruff, Janet H. Ford, Antje Tockhorn-Heidenreich, Virginia L. Stauffer, Sriram Govindan
European Journal of Neurology. 2020-04-01 - 21 citationsEffect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraineMichael Ament, Kathleen Day, Virginia L. Stauffer, Vladimir Skljarevski, Mallikarjuna Rettiganti
The Journal of Headache and Pain. 2021-02-06 - 178 citationsMagnetoencephalographic fields from patients with spontaneous and induced migraine aura.Susan M. Bowyer, Sheena K. Aurora, John E. Moran, Norman Tepley, K. M. A. Welch
Annals of Neurology. 2001-11-01
Press Mentions
Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray Is Safe to Use When Co-Administered with Commonly Prescribed Migraine MedicationsApril 26th, 2023- Why the Key to Stopping Your Migraine Attack May Be Right Under Your NoseJune 2nd, 2022
- Impel NeuroPharma to Present Trudhesa™ Data at 2022 Scientific Meeting of American Academy of NeurologyMarch 22nd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
